Nephrol Dial Transplant (1999) 14: 2413-2419
© 1999 European Renal Association-European Dialysis and Transplant Association
PDGF-AB release during and after haemodialysis procedure
Institute of Nephrology, St. Orsola University Hospital, Bologna, Italy
Correspondence and offprint requests to: Dr Giuseppe Cianciolo, Servizio di Nefrologia e Dialisi, Policlinico S. Orsola, Via Massarenti 9, I-40138 Bologna, Italy.
Background. During haemodialysis blood–membrane contact causes the release of the content of platelet 
-granules, which contain platelet-derived growth factor (PDGF). In view of its possible role in accelerated atherosclerotic processes, we evaluated the intra- and post-dialytic changes in PDGF-AB serum levels during haemodialysis sessions performed using a cellulosic membrane.
Methods. Using the ELISA method, PDGF-AB, platelet factor-4 (PF4) and ß-thromboglobulin (ß-TG) levels were determined in peripheral blood, as well as in arterial and venous haemodialyser lines, in 10 patients each of whom underwent five consecutive dialysis sessions with a CU membrane. Blood samples were taken at 0, 15, 30, 60, 120, 180 and 240 min during dialysis and at 1, 4 and 20 h after the end of the session. In the same group of patients the levels of the same molecules were also determined after a heparin bolus injection of 4500 IU, blood samples were taken at 0, 15 and 30 min after injection of the bolus.
Results. PDGF-AB serum levels increased, remained consistently high during the haemodialysis session (in particular +134±20% after 30 min, P<0.001, and +140±5% after 240 min, P<0.001) and returned to basal values only after 20 h following the end of the session. PF4 and ß-TG showed a similar trend to PDGF. The heparin bolus injection caused only a small increase (+15±5% at 30 min) in PDGF-AB serum levels.
Conclusions. PDGF-AB is released during dialysis mainly as consequence of the blood–membrane contact and it returns only slowly to basal values.
Keywords: accelerated atherosclerosis; dialysis; growth factors; platelet activation; platelet-derived growth factor
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  P. Boor, F. Eitner, C. D. Cohen, M. T. Lindenmeyer, for the ERCB-Consortium, P. R. Mertens, T. Ostendorf, and J. Floege Patients with IgA nephropathy exhibit high systemic PDGF-DD levels Nephrol. Dial. Transplant., April 14, 2009; (2009) gfp152v2. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Kanter, S. Y. Khan, M. Kelher, L. Gore, and C. C. Silliman Oncogenic and Angiogenic Growth Factors Accumulate during Routine Storage of Apheresis Platelet Concentrates Clin. Cancer Res., June 15, 2008; 14(12): 3942 - 3947. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Zimmermann, J. Koenig, J. Zingsem, V. Weisbach, E. Strasser, J. Ringwald, and R. Eckstein Effect of Specimen Anticoagulation on the Measurement of Circulating Platelet-Derived Growth Factors Clin. Chem., December 1, 2005; 51(12): 2365 - 2368. [Full Text] [PDF]
|
|
|
|
|
|
G. Cianciolo, S. Stefoni, G. Donati, A. D. Pascalis, S. Iannelli, C. Manna, L. Coli, V. Bertuzzi, G. L. Manna, C. Raimondi, et al. Intra- and post-dialytic platelet activation and PDGF-AB release: cellulose diacetate vs polysulfone membranes Nephrol. Dial. Transplant., June 1, 2001; 16(6): 1222 - 1229. [Abstract] [Full Text] [PDF]
|
|